These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 17868195

  • 1. Modafinil and nicotine interactions in abstinent smokers.
    Sofuoglu M, Waters AJ, Mooney M.
    Hum Psychopharmacol; 2008 Jan; 23(1):21-30. PubMed ID: 17868195
    [Abstract] [Full Text] [Related]

  • 2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S.
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [Abstract] [Full Text] [Related]

  • 3. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
    Sofuoglu M, Babb D, Hatsukami DK.
    Nicotine Tob Res; 2003 Dec; 5(6):947-53. PubMed ID: 14668079
    [Abstract] [Full Text] [Related]

  • 4. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
    Demazières A, Luthringer R, Coppel E, Gilles C, Fleury C, Roegel JC, Delarue A, Laur C, Lagrue G.
    Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703
    [Abstract] [Full Text] [Related]

  • 5. Adrenergic blocker carvedilol attenuates the cardiovascular and aversive effects of nicotine in abstinent smokers.
    Sofuoglu M, Mouratidis M, Yoo S, Kosten T.
    Behav Pharmacol; 2006 Dec; 17(8):731-5. PubMed ID: 17110799
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G, Lemmonds CA, Kotler ML, Durcan MJ, Boyle J.
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [Abstract] [Full Text] [Related]

  • 7. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
    Knott VJ, Fisher DJ.
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
    [Abstract] [Full Text] [Related]

  • 8. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.
    Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ.
    Biol Psychiatry; 2004 May 15; 55(10):1031-40. PubMed ID: 15121488
    [Abstract] [Full Text] [Related]

  • 9. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP, Rush CR, Frederich RC, Taylor AC, Kelly TH.
    Exp Clin Psychopharmacol; 2007 Apr 15; 15(2):123-33. PubMed ID: 17469936
    [Abstract] [Full Text] [Related]

  • 10. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L, Busto UE, MacDonald A, Corrigall WA.
    Can J Clin Pharmacol; 2002 Apr 15; 9(4):175-82. PubMed ID: 12584575
    [Abstract] [Full Text] [Related]

  • 11. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):552-9. PubMed ID: 18053628
    [Abstract] [Full Text] [Related]

  • 12. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE, Griffiths RR.
    Psychopharmacology (Berl); 2003 Jan 15; 165(3):280-90. PubMed ID: 12434259
    [Abstract] [Full Text] [Related]

  • 13. Behavioral effects of modafinil and nicotine, alone and in combination, in tobacco-deprived young adult smokers.
    Martin CA, Lile J, Guenthner G, Anestis JC, Batten SR, Kelly TH.
    J Clin Psychopharmacol; 2014 Apr 15; 34(2):278-81. PubMed ID: 24525639
    [No Abstract] [Full Text] [Related]

  • 14. Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome.
    Randall DC, Cafferty FH, Shneerson JM, Smith IE, Llewelyn MB, File SE.
    J Psychopharmacol; 2005 Nov 15; 19(6):647-60. PubMed ID: 16272188
    [Abstract] [Full Text] [Related]

  • 15. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
    Cousins MS, Stamat HM, de Wit H.
    Nicotine Tob Res; 2001 May 15; 3(2):123-9. PubMed ID: 11403726
    [Abstract] [Full Text] [Related]

  • 16. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.
    Sofuoglu M, Poling J, Mouratidis M, Kosten T.
    Psychopharmacology (Berl); 2006 Mar 15; 184(3-4):645-51. PubMed ID: 16432681
    [Abstract] [Full Text] [Related]

  • 17. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE, Griffiths RR.
    J Pharmacol Exp Ther; 2001 Feb 15; 296(2):486-94. PubMed ID: 11160635
    [Abstract] [Full Text] [Related]

  • 18. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.
    Sofuoglu M, Mouratidis M, Yoo S, Culligan K, Kosten T.
    Psychopharmacology (Berl); 2005 Sep 15; 181(3):504-10. PubMed ID: 15983800
    [Abstract] [Full Text] [Related]

  • 19. Cognitive enhancing effects of modafinil in healthy volunteers.
    Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ.
    Psychopharmacology (Berl); 2003 Jan 15; 165(3):260-9. PubMed ID: 12417966
    [Abstract] [Full Text] [Related]

  • 20. Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study.
    Gill M, Haerich P, Westcott K, Godenick KL, Tucker JA.
    Acad Emerg Med; 2006 Feb 15; 13(2):158-65. PubMed ID: 16436796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.